By Pushkala Aripaka and Patrick Wingrove Oct 30 (Reuters) - AstraZeneca unveiled plans on Friday to save about $1.5 billion ...

Pascal Soriot spoke exclusively with CNBC from the site of AstraZeneca's new $1 billion R&D facility in Kendall Square in Cambridge, Massachusetts.

By Sabrina Valle, Milana Vinn and Amy-Jo Crowley Nov 4 (Reuters) - AstraZeneca made an offer of about $10 billion to acquire ...

AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was "rapidly transferring manufacturing" across the Atlantic. "This country [the U.S.] ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

AstraZeneca announced forecast-beating revenue on Tuesday. AstraZeneca's chief executive on Tuesday teased the prospect of a weight-loss drug in development that the company moved into late-stage ...

ASTRAZENECA made an offer of about $10 billion to acquire obesity drugmaker Rhythm Pharmaceuticals, according to three people familiar with the matter.

Akeso CEO Michelle Xia, Ph.D., called AstraZeneca’s investment in Summit Therapeutics “a very smart move” because the money ...